CVC  Penn Medicine

https://www.pennmedicine.org/





     Office Locations:

Perelman Center for Advanced Medicine
3400 Civic Center Boulevard
Philadelphia, PA 19104
Phone: 800-789-7366

 

Stages:

  • Early
  • Growth


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    Penn Medicine is a company co-founded by Penn faculty and researchers. Penn Medicine includes the University of Pennsylvania Health System and the university's Perelman School of Medicine. Penn Medicine will invest in companies in the healthcare sector, providing additional medical research and education services.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Christine VanZandbergen Associate CIO
    John Donohue Associate CIO of Technology & Infrastructure
    Michael Draugelis Chief Data Scientist

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      01/16/2018


      Tissue Analytics


      MD


      $5,000,000


      Series A


     

    Portfolio companies include:

     

    Recent News:


      There is no recent news for Penn Medicine.